Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Nuvalent Details Strategy to Seek First Potential Approval in 2026 and Outlines Key Anticipated 2025 Milestones PR Newswire CAMBRIDGE, Mass., Jan. 13, 2025 Strategy prioritizes most accelerated...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.125 | -1.46170337166 | 76.965 | 78.1785 | 69.58 | 662000 | 74.32991547 | CS |
4 | -7.965 | -9.50420619295 | 83.805 | 87.315 | 69.58 | 557053 | 78.40622322 | CS |
12 | -17.82 | -19.0262652146 | 93.66 | 97.65 | 69.58 | 468480 | 86.16479745 | CS |
26 | -6.54 | -7.93882010197 | 82.38 | 113.51 | 64.67 | 460468 | 90.45302561 | CS |
52 | 2.92 | 4.00438837082 | 72.92 | 113.51 | 61.795 | 445157 | 83.11298963 | CS |
156 | 63.51 | 515.085158151 | 12.33 | 113.51 | 7.09 | 362182 | 57.86705977 | CS |
260 | 57.74 | 319.005524862 | 18.1 | 113.51 | 7.09 | 333778 | 55.90656108 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관